The definition
Peptide therapy refers to the use of peptide molecules — short amino-acid chains — as the active agent influencing a biological pathway. The umbrella covers approved pharmaceutical peptides (e.g. insulin, semaglutide, tirzepatide), older clinical peptides (e.g. oxytocin, desmopressin) and a large body of research peptides used in laboratory and preclinical contexts.
Why peptides are interesting therapeutically
Peptides can bind their target receptors with high selectivity, which means small doses can produce specific effects with — in principle — fewer off-target interactions than smaller-molecule drugs. They are also produced by predictable solid-phase chemistry, so identity and purity can be tightly controlled at the manufacturing stage.
Common peptide families in this discussion
Metabolic peptides (GLP-1 analogues such as semaglutide and tirzepatide, and triple agonists such as retatrutide). Regenerative peptides (BPC-157, TB-500). Growth-hormone-related peptides (CJC-1295, Ipamorelin, MK-677 which is technically not a peptide but is often grouped with them). Cosmetic peptides (GHK-Cu, copper peptide complexes). Mitochondrial peptides (SS-31, MOTS-c). Each family has its own literature base.
Approved vs research-only
A small subset of peptides are approved pharmaceutical therapies for specific indications — semaglutide for type-2 diabetes and weight management, tirzepatide for similar indications, insulin for diabetes, oxytocin in obstetrics, and others. The much larger set of compounds discussed as 'peptide therapy' in research and clinic-adjacent contexts are sold for laboratory research use only and are not approved for human consumption.
What the evidence does and does not show
Approved peptide pharmaceuticals have large randomised-controlled-trial datasets behind their licensed indications. Many research peptides have promising preclinical or early-clinical data but no Phase 3 outcomes. Confusing the two is the most common misunderstanding in this space. Always read the primary literature for the specific compound.
Where to go next
If you are evaluating a specific compound, the Peptide Library and the per-compound research pages (semaglutide, tirzepatide, retatrutide, BPC-157, GHK-Cu) cover handling and batch data. The research disclaimer page outlines the use context that applies to research-grade material.
Frequently asked questions
What is peptide therapy in simple terms?+
Peptide therapy is the use of peptide molecules — short chains of amino acids — to influence specific biological pathways. The term covers both approved pharmaceutical peptides and a much larger set of research peptides not approved for human use.
Is peptide therapy FDA-approved?+
Specific peptides have FDA-approved pharmaceutical forms for specific indications (e.g. semaglutide, tirzepatide, insulin). 'Peptide therapy' as a broader umbrella often refers to off-label or research-only uses that are not approved.
What conditions are studied in peptide therapy research?+
Active areas include metabolic disease (GLP-1 family), tissue regeneration (BPC-157, TB-500), growth-hormone pathways, dermatological models (GHK-Cu) and mitochondrial biology (SS-31, MOTS-c). Most of this is preclinical or early-clinical.
Are peptides the same as hormones?+
Some hormones are peptides (e.g. insulin, oxytocin, GLP-1). Others are not (e.g. steroid hormones like testosterone are lipids, not peptides). 'Peptide hormone' is a specific subset of the broader peptide class.
Continue your research
What are peptides?
Are peptides safe?
Is Ozempic a peptide?
Book a free consultation
Peptide Library
Browse the full HPLC-verified catalogue
Buy in Marbella
Local delivery across Costa del Sol
Book a free consultation
20-minute call with the Regena team
Lab reports & COAs
Batch-by-batch purity certificates
Research compounds overview
Laboratory peptides guide
Storage & reconstitution guide
Peptide glossary